Integrated Diagnostics (OTCMKTS:IDGXF) Stock Falls 19.9% – Should You Sell?

Integrated Diagnostics Holdings plc (OTCMKTS:IDGXF – Get Free Report)’s stock price dropped 19.9% on Friday. The stock traded as low as $0.47 and last traded at $0.47. Approximately 4,290 shares changed hands during trading, an increase of 103% from the average daily volume of 2,117 shares. The stock had previously closed at $0.5870.

Integrated Diagnostics Stock Performance

The business has a 50 day moving average price of $0.55 and a 200-day moving average price of $0.59.

Integrated Diagnostics Company Profile

(Get Free Report)

Integrated Diagnostics Holdings PLC (IDH), traded in the United States under the symbol IDGXF, is a healthcare company focused on medical diagnostic services. Through its laboratory brands and collection centers, it provides testing to patients, physicians, hospitals and other healthcare providers.

The company offers a broad range of clinical laboratory tests, including routine and specialized diagnostics. Its services support areas such as pathology, clinical chemistry, microbiology and molecular testing.

IDH’s network has included operations in Egypt, Jordan, Nigeria and Sudan.

Recommended Stories

Receive News & Ratings for Integrated Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integrated Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.